In clinical practice, histological grade, expression of estrogen and progesterone receptors (ER and PgR), overexpression of the human epidermal growth factor receptor 2 (HER2) oncogene, and proliferative activity, measured by ki-67, represent crucial parameters that provide important information on the biology of BC, which then guide the choice of treatment. The gene discussed is ERBB2; the disease is breast cancer.